Formation kinetics and stability of carbamazepine-nicotinamide cocrystals prepared by mechanical activation

Crystal Growth and Design

Volumn 9, Issue 5, 2009, Pages 2377-2386

  Chieng, Norman ^a   Hubert, Madlen ^a   Saville, Dorothy ^a   Rades, Thomas ^a   Aaltonen, Jaakko ^a,b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 66249096287     PISSN: 15287483     EISSN: 15287505     Source Type: Journal    
DOI: 10.1021/cg801253f     Document Type: Article

References (29)

1. Shan, N.; Zaworotko, M. J. The role of cocrystals in pharmaceutical science. Drug DiscoVery Today 2008, 13 (9-10), 440-446.
2. Remenar, J. F.; Morissette, S. L.; Peterson, M. L.; Moulton, B.; MacPhee, J. M.; Guzman, H. R.; Almarsson, O. Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids. J. Am. Chem. Soc. 2003, 125, 8456-8457. (Pubitemid 36858412)
3. Almarsson, O.; Zaworotko, M. Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical cocrystals represent a new path to improve medicines° Chem. Commun. 2004, 1889-1896. (Pubitemid 39335992)
4. Joint Formulary Committee; British National Formulary; British Medical Association and Royal Pharmaceutical Society of Great Britain: London, 2008; Vol.55.
5. Rustichelli, C.; Gamberini, G.; Ferioli, V.; Gamberini, M.; Ficarra, R.; Tommasini, S. Solid-state study of polymorphic drugs: Carbamazepine. J. Pharm. Biomed. Anal. 2000, 23, 41-54. (Pubitemid 30394550)
6. Grzesiak, A. L.; Lang, M.; Kim, K.; Matzger, A. J. Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of the form 1. J. Pharm. Sci. 2003, 92 (11), 2260-2271. (Pubitemid 37356699)
7. Behme, R. J.; Brooke, D. Heat of fusion measurement of a low melting polymorph of carbamazepine that undergoes multiple-phase changes during differential scanning calorimetry analysis. J. Pharm. Sci. 1991, 80 (10), 986-990.
8. Hickey, M. B.; Peterson, M. L.; Scoppettuolo, L. A.; Morrisette, S. L.; Vetter, A.; Guzman, H.; Remenar, J. F.; Zhang, Z.; Tawa, M. D.; Haley, S.; Zaworotko, M. J.; Almarsson, O. Performance comparison of a cocrystal of carbamazepine with marketed product. Eur. J. Pharm. Biopharm. 2007, 67 (1), 112-119. (Pubitemid 46991320)
9. Amidon, G. L.; Lennernäs, H.; Shah, V. P.; Crison, J. R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in Vitro drug product dissolution and in ViVo bioavailability. Pharm. Res. 1995, 12 (3), 413-420.
10. Tian, F.; Sandler, N.; Aaltonen, J.; Lang, C.; Saville, D.; Gordon, K. C.; Strachan, C. J.; Rantanen, J.; Rades, T. Influence of polymorphic form, morphology, and excipient interactions on the dissolution of carbamazepine compacts. J. Pharm. Sci. 2007, 96 (3), 584-594. (Pubitemid 46466080)
11. Lehto, P.; Aaltonen, J.; Tenho, M.; Rantanen, J.; Hirvonen, J.; Tanninen, V. P.; Peltonen, L. Solvent-mediated solid phase transformations of carbamazepine: Effects of simulated intestinal fluid and fasted state simulated intestinal fluid. J. Pharm. Sci. 2009, 985-996.
12. Vishweshwar, P.; McMahon, J. A.; Bis, J. A.; Zaworotko, M. J. Pharmaceutical cocrystals. J. Pharm. Sci. 2006, 95 (3), 499-516.
13. Fleischman, S. G.; Kuduva, S. S.; McMahon, J. A.; Moulton, B.; BaileyWalsh, R. D.; Rodriguez-Hornedo, N.; Zaworotko, M. J. Crystal engineering of the composition of pharmaceutical phases: multiplecomponent crystalline solids involving carbamazepine. Cryst. Growth Des. 2003, 3 (6), 909-919. (Pubitemid 37474229)
14. Hino, T.; Ford, J. L.; Powell, M. W. Assessment of nicotinamide polymorphs by differential scanning calorimetry. Thermochim. Acta 2001, 374, 85-92.
15. Seefeldt, K.; Miller, J.; Alvarez-Núnez, F.; Rodríguez- Hornedo, N. Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies. J. Pharm. Sci. 2007, 96 (5), 1147-1158. (Pubitemid 46797483)
16. Jayasankar, A.; Good, D. J.; Rodriguez-Hornedo, N. Mechanisms by which moisture generates cocrystals. Mol. Pharmaceutics 2007, 4 (3), 360-372. (Pubitemid 46983953)
17. Jayasankar, A.; Somwangthanaroj, A.; Sirinutsomboon, B.; Shao, Z. J.; Rodriguez-Hornedo, N. cocrystal formation by solid-state grinding and during storage. AAPS J. 2004, 6, R6159.
18. Porter(III), W. W.; Elie, S. C.; Matzger, A. J. Polymoprhism in carbamazepine cocrystals. Cryst. Growth Des. 2008, 8 (1), 14-16.
19. Grzesiak, A. L.; Lang, M.; Kim, K.; J., M. A. Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of the form 1. J. Pharm. Sci. 2003, 92 (11), 2260-2271. (Pubitemid 37356699)
20. Beebe, K.; Pell, R.; Seasholtz, M. Chemometrics: A Practical Guide; John Wiley & Sons, Inc: New York, 1998.
21. Geladi, P.; MacDougall, D.; Martens, H. Linearization and Scattercorrection for near-infrared reflectance spectra of meat. Appl. Spectrosc. 1985, 39 (3), 491-500.
22. Jørgensen, A. C.; Miroshnyk, I.; Karjalainen, M.; Jouppila, K.; Siiriä, S.; Antikainen, O.; Rantanen, J. Multivariate data analysis as a fast tool in evaluation of solid state phenomena. J. Pharm. Sci. 2006, 95 (4), 906-916.
23. Hino, T.; Ford, J. L. Characterization of the hydroxypropylmethylcellulose- nicotinamide binary system. Int. J. Pharm. 2001, 219 (1-2), 39-49. (Pubitemid 32391363)
24. Rodriguez-Hornedo, N.; Nehm, S. J.; Jayasankar, A., cocrystal: design, properties and formation mechanism. In Encyclopedia of Pharmaceutical Technology, 3rd ed.; Swarbrick, J., Ed.; Informa Healthcare, USA: 2007; pp 615-635.
25. Jayasankar, A.; Somwangthanaroj, A.; Shao, Z.; Rodríguez- Hornedo, N. cocrystal formation during cogrinding and storage is mediated by amorphous phase. Pharm. Res. 2006, 23 (10), 2381-2392. (Pubitemid 44511518)
26. Karki, S.; Fris°c°ić, T.; Jones, W.; Motherwell, W. D. S. Screening for pharmaceutical cocrystal hydrates via neat and liquid-assisted grinding. Mol. Pharmaceutics 2007, 4 (3), 347-354. (Pubitemid 46983951)
27. Harris, R.; Ghi, P.; Puschmann, H.; Apperley, D.; Griesser, U.; Hammond, R.; Ma, C.; Roberts, K.; Pearce, G.; Yates, J.; Pickard, C. Structural studies of the polymorphs of carbamazepine, its dihydrate and two solvates. Org. Process Res. DeV. 2005, 9 (6), 902-910. (Pubitemid 41784114)
28. Chieng, N.; Zujovic, Z.; Bowmaker, G.; Rades, T.; Saville, D. Effect of milling conditions on the solid-state conversion of ranitidine hydrochloride form 1. Int. J. Pharm. 2006, 327 (1-2), 35-44. (Pubitemid 44667333)
29. Chieng, N.; Rades, T.; Saville, D. Formation and physical stability of the amorphous phase of ranitidine hydrochloride polymorphs prepared by cryo-milling. Eur. J. Pharm. Biopharm. 2008, 68 (3), 771-780.